ArticleFrontiers in bioinformatics2026
Towards a holistic epidemiology of
Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: To move beyond region- or outbreak-limited studies, this work has analyzed 37970 Results: The dataset largely matched the known population structure with serotype III, Ia, and V most common and stable serotype/clonal complex lineages (e.g., III-2/CC17, Ia/CC23, CC1/V), while also increasing serotype diversity. Lineages differed in their accessory-gene profiles, with III-2/CC17 being enriched for virulence and adhesion genes, while other groups showed either greater genomic plasticity (mobile/phage genes) or niche specialization. AMR was widespread with very high tetracycline resistance (>80%), frequent MLSB resistance determinants, and emerging aminoglycoside resistance in some genomes. Conclusions: Overall, it became evident that the associated metadata contained substantial gaps. Missing or incomplete information limits biological interpretation, pointing out the importance of rigorously curated, structured metadata for maximizing the value of ongoing sequencing efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.